Insiders · JSPR

JSPR insider transactions

Jasper Therapeutics Inc. (JSPR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for JSPR

• 118d
  SEC Form 4 filed by CEO and President Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 154d
  SEC Form 4 filed by President, CEO and Director Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 154d
  SEC Form 4 filed by Chief Operating Officer Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 154d
  SEC Form 4 filed by Chief Financial Officer Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 257d
  Director Wiggans Thomas G bought $99,630 worth of Voting Common Stock (41,000 units at $2.43) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 257d
  Director Lucas Svetlana bought $48,600 worth of Voting Common Stock (20,000 units at $2.43) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 257d
  President and CEO Martell Ron bought $99,630 worth of Voting Common Stock (41,000 units at $2.43), increasing direct ownership by 124% to 74,118 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 257d
  Director Shizuru Judith Anne bought $99,630 worth of Voting Common Stock (41,000 units at $2.43), increasing direct ownership by 35% to 156,901 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Emster Kurt Von

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Shizuru Judith Anne

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Nolet Chris

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Kapoor Vishal

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Wiggans Thomas G

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 340d
  SEC Form 4 filed by Director Lucas Svetlana

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 367d
  SEC Form 4 filed by President and CEO Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 367d
  SEC Form 4 filed by Chief Operating Officer Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 367d
  SEC Form 4 filed by Chief Financial Officer Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 367d
  SEC Form 4 filed by Chief Medical Officer Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 475d
  SEC Form 4 filed by Chief Operating Officer Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 475d
  SEC Form 4 filed by President, CEO and Director Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 475d
  SEC Form 4 filed by Chief Financial Officer Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 475d
  SEC Form 4 filed by Chief Medical Officer Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 543d
  Chief Operating Officer Mahal Jeetinder Singh sold $19,899 worth of Voting Common Stock (900 units at $22.11) and exercised 900 units of Voting Common Stock at a strike of $7.10 (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 634d
  Chief Operating Officer Mahal Jeetinder Singh exercised 900 units of Voting Common Stock at a strike of $7.10 and sold $19,104 worth of Voting Common Stock (900 units at $21.23) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 718d
  SEC Form 4 filed by Director Lucas Svetlana

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 718d
  SEC Form 3 filed by new insider Lucas Svetlana

  3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 726d
  Chief Operating Officer Mahal Jeetinder Singh exercised 900 units of Voting Common Stock at a strike of $7.10 and sold $21,740 worth of Voting Common Stock (900 units at $24.16) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 726d
  SEC Form 4 filed by President, CEO and Director Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  Chief Medical Officer Tucker Edwin Jonathan was granted 400 units of Voting Common Stock (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director French Anna Louise

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director Nolet Chris

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director Shizuru Judith Anne

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director Kapoor Vishal

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director Wiggans Thomas G

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 728d
  SEC Form 4 filed by Director Emster Kurt Von

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 818d
  Mahal Jeetinder Singh exercised 900 units of Voting Common Stock at a strike of $7.10 and sold $23,792 worth of Voting Common Stock (900 units at $26.44) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 839d
  SEC Form 4 filed by Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 839d
  SEC Form 4 filed by Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 839d
  SEC Form 4 filed by Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 839d
  SEC Form 4 filed by Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 847d
  Carlyle Group Inc. bought $2,460,500 worth of Voting Common Stock (190,000 units at $12.95) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 850d
  Velan Capital Investment Management Lp bought $4,532,500 worth of shares (350,000 units at $12.95) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 921d
  Wiggans Thomas G bought $6,486 worth of Voting Common Stock (10,000 units at $0.65), increasing direct ownership by 25% to 50,000 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 931d
  Wiggans Thomas G bought $18,240 worth of Voting Common Stock (30,000 units at $0.61) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 949d
  SEC Form 4 filed by Wiggans Thomas G

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 949d
  SEC Form 3 filed by new insider Wiggans Thomas G

  3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 969d
  Mahal Jeetinder Singh covered exercise/tax liability with 37,126 units of Voting Common Stock, decreasing direct ownership by 13% to 250,097 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 969d
  Martell Ron covered exercise/tax liability with 87,531 units of Voting Common Stock, decreasing direct ownership by 21% to 331,188 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 969d
  Lis William sold $6,777 worth of Voting Common Stock (7,965 units at $0.85), decreasing direct ownership by 13% to 53,521 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 986d
  SEC Form 4 filed by Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 986d
  SEC Form 3 filed by new insider Cross Herb

  3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1084d
  SEC Form 3 filed by new insider Brun Scott C.

  3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1084d
  SEC Form 4 filed by Brun Scott C.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1091d
  SEC Form 4 filed by Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1091d
  SEC Form 4 filed by Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1091d
  SEC Form 3 filed by new insider Tucker Edwin Jonathan

  3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1096d
  SEC Form 4 filed by Kapoor Vishal

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1096d
  SEC Form 4 filed by Klein Lawrence Otto

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)